SlideShare a Scribd company logo
1 of 40
PRESENTATION:
INTERNAL MEDICINE:
GROUP 3
LECTURERS:DR. SHERIFF AND DR.MARTIN
 Mohamed lahai marrah (Leader)…..22065
 Mohamed Adams jalloh……………..22027
 Bandatin wilem conteh………………22014
 Marian muyo kanu……………………22051
 Kelfala hassan dawoh………………..22019
 Foray kondeh ………………………….22056
 Mohamed Alieu jalloh………………..22026
Definition of peptic ulcer.
Location and symptoms.
Types.
Etiology.
Pathophysiology and pathogenesis
Signs & symptoms
Complications ,diagnostic studies and treatment.
Precautions.
• Peptic ulcer disease (PUD) refers to ulceration of the
mucosa anywhere in the GI tract exposed to acid and
pepsin.
• Ulcers : breaks in the mucosal surface >5 mm, with depth
to the sub-mucosa.
• They can range in size from a few millimeters to a few
centimeters
• The 2 most common forms/locations of PUD are
– Duodenal ulcer
– Gastric ulcer
 Site
• Lower esophagus
• Stomach
• Duodenum
 Under normal conditions, a physiologic balance
exists between gastric acid secretion and
gastroduodenal mucosal defense. Mucosal injury
and, thus, peptic ulcer occur when the balance
between the aggressive factors and the defensive
mechanisms is disrupted. Aggressive factors,
such as NSAIDs, H pylori infection, alcohol, bile
salts, acid, and pepsin, can alter the mucosal
defense by allowing back diffusion of hydrogen
ions and subsequent epithelial cell injury.
 Defensive
◦ Bicarbonate
◦ Mucus layer
◦ Prostaglandins
◦ Mucosal blood flow
◦ Epithelial renewal
 Aggressive
◦ Helicobacter pylori
◦ NSAIDs
◦ Pepsins
◦ Bile acids
◦ Smoking and alcohol
Ulcer may be found :
In oesophagus,
 stomach,
duedonum
jejunum at multiple
levels (Zollinger Ellison
syndrome).
Acute
• Superficial erosion
• Minimal erosion
Chronic
• Muscular wall erosion with formation of fibrous
tissue
• Present continuously for many months or
intermittently
• Common causes of PUD
– Helicobacter pylori (H.pylori) infection
– Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
– Critical illness (stress-related mucosal damage)
• Uncommon causes of PUD
– Idiopathic (non-H.pylori, non- NSAID)
– Hypersecretion of gastric acid (e.g. Zollinger
Ellison syndrome)
– Viral infections
– Radiation therapy
– Chemotherapy
 Helicobacter pylori (HP) is a spiral shaped,
gram negative, flagellated bacteria first
associated with PUD in the early 1980’s
 Found in most people with duodenal and
gastric ulcers
◦ About 95% of those with duodenal ulcers
◦ About 80% of those with gastric ulcers
 HP is primarily spread through the fecal to oral
route
 Oral – oral routes
 Through contaminated food and water
 People are most often infected during
childhood
 Mechanisms by which HP causes mucosal injury
are not entirely clear but occurs through a
combination of the following mechanisms:
◦ HP catalyzes urea  ammonia is produced  ammonia
erodes the mucous barrier and causes epithelial damage
◦ HP produces cytotoxins
◦ HP produces mucolytic enzymes
PATHOGENESIS
 In long-term NSAID users, there is a 10% - 20%
prevalence of gastric ulcers and a 2% - 5% prevalence
of duodenal ulcers
 Mechanisms for NSAID-induced ulceration
◦ NSAIDs are weak acids and are non-ionized at gastric
pH
 Diffuse freely across the mucous barrier into gastric
epithelial cells  H+ ions are liberated and cause cellular
damage
• Aspirin is the most ulcerno-genic of all NSAIDs.
– Even with low dose aspirin (81-162mg/day), ulcers
occur in 0.6% - 1.2% of patients per year
• NSAIDs inhibit cyclooxygenase activity and
therefore decrease prostaglandin
production which results in a:
 Reduction in gastric and mucosal blood
flow
 Decrease in mucous and bicarbonate
secretion
 Decrease in cellular repair and replication
• ZES is characterized by gastric acid
hypersecretion and recurrent peptic ulcers that
result from a gastrin-producing tumor
–More than 50% of gastrinomas are malignant
• ZES is suspected for patients with multiple
ulcers and recurrent or refractory PUD often
accompanied by esophagitis or ulcer
complications
• Only accounts for 0.1% to 1% of those with
duodenal ulcer
• Cigarette smoking
– Impairs ulcer healing and increases the risk of
recurrence
• Psychological stress
– Stress may induce behavioral risks such as
smoking and the use of NSAIDs or may alter the
inflammatory response or resistance to HP
infection
• Dietary factors
– Certain foods (e.g. coffee, tea, carbonated
beverages, beer, milk, spices) may cause
dyspepsia but do not increase the risk of
developing PUD
Signs &Symptoms
Abdominal discomfort usually occurs in epigastric area
(upper middle part of the abdomen) radiating to the back
described as:
dull gnawing ache comes and goes for several days
pain may increase when the stomach is empty at night or
half to three hours after meal.
Pain is relieved by eating & antacid medication.
Weight change
Fatigue
Bloating
Chest pain
Burping
Nausea and Anorexia (common with gastric ulcer)
Vomiting (relieves episodes of severe pain due to evacuation
of gastric acid content).
Heart burn
Emergency symptoms:
If you have any of these symptoms call your
doctor right away:
Sharp sudden persistent abdominal pain.
Bloody or black stools.
Bloody vomit or vomit that looks like coffee
grounds.
Dysphagia
They could be signs of a serious problem such as:
Perforation when the ulcer burrows through
the stomach or duodenal wall.
 Less common than duodenal ulcers
◦ Especially in chronic NSAID use
 Most commonly located in the lesser curvature of the antrum of the
stomach
 More common in people greater than 60 years old
Characterized by
• A normal to low secretion of gastric acid
• Back diffusion of acid is greater (chronic )
• Critical pathologic process is amount of acid able to penetrate mucosal barrier
• H pylori is present in 50% to 70%
• Drugs --- Aspirin, corticosteroids, N SAIDs, reserpine, Chronic alcohol abuse,
chronic gastritis
 Most common form of PUD
◦ It is 3 times more common than gastric ulcers
 Usually located in the duodenal bulb of the small
intestine
 Most commonly occurs in people between the
ages of 30 and 50
 Associated with ↑HCl acid secretion
 H.pylori associated in 9 0- 9 5 % of cases
 Diseases with ↑risk of duodenal ulcers
COPD, cirrhosis of liver, chronic pancreatitis,
hyperparathyroidism, chronic renal failure
 3 major complications
Hemorrhage - 15% of patients with active PUD
Perforation - 7% of patients with active PUD
Gastric outlet obstruction
 Initially treated conservatively
 May require surgery at any time during
course of therapy
 The second most common ulcer – related
complications is perforation( occur in 6-7% of
PUD patients)
 Dus tend to penetrate posteriorly in to the
pancrease, leading to pancreatitis, whereas
Gus tend to penetrate in to the left hepatic
lobe.
 Gastric outlet obstruction is the least
common ulcer-related
complications,occuring in 1-2% of patients
 Endoscopy procedure
◦ Determines degree of ulcer healing after treatment
◦ Tissue specimens can be obtained to identify H. pylori and to rule
out gastric cancer
 Tests for H.pylori
◦ Noninvasive tests
 Serum or whole blood antibody tests
 Immunoglobin G (I g G)
 Urea breath test
 C 14 breath test
 Fecal antigen test
◦ Invasive tests
 Biopsy of stomach
 Rapid urease test
 The urea breath and fecal antigen tests may be
falsely negative in patients who have recently
taken
◦ Antibiotics (up to 4 weeks)
◦ Bismuth compounds (up to 4 weeks)
◦ Antisecretory agents (up to 2 weeks)
 Barium contrast studies
◦ Widely used
 X- ray studies
◦ Ineffective in differentiating a peptic ulcer from a
malignant tumor
Medical regimen consists of
◦ Adequate rest
◦ Dietary modification
◦ Drug therapy
◦ Elimination of risk factors
◦ Long-term follow-up care
• Antacids
• H2 receptor blockers
• PPIs
• Antibiotics
• Anticholinergics
• Cytoprotective therapy
Histamine receptor blocks (H2 R blockers)-
famotidine,cimetidine
 Used to manage peptic ulcer disease
 Block action of histamine on H2 receptors
↓ HCl acid secretion
↓ conversion of pepsinogen to pepsin
↑ ulcer healing
Proton pump inhibitors – pantoprazole,
rabeprazole
◦ Block ATPase enzyme that is important for secretion
of HCl acid
Antibiotic therapy
◦ Eradicate H. pylori infection
◦ No single agents have been effective in eliminating H.
pylori
 Antacids – calcium carbonate, MgOH
◦ Used as adjunct therapy for peptic ulcer disease
◦ ↑ gastric pH by neutralizing acid
 Anticholinergic drugs- Dicyclomine
◦ Occasionally ordered for treatment
◦ ↓ cholinergic stimulation of HCl acid
• Bismuth preparations
• Agents
– Bismuth subsalicylate
– Bismuth exhibits antimicrobial activity against
bacterial and viral gastrointestinal pathogens
 Standard triple therapy regimen contains
◦ Amoxicillin 1000mg twice day + Clarithromycin 500mg
twice a day + a PPI dosed once to twice a day
◦ Given for 10 to 14 days
 14 day regimens are generally preferred as 14 day
regimens significantly increases the eradication rate
 Bismuth-based quadruple-therapy contains
◦ Tetracycline 500mg 4 times day +Metronidazole 250-
500mg 2/3 times a day + Bismuth subsalicylate 525mg 4
times a day + a PPI once or twice a day OR H2-receptor
antagonist twice a day
• When symptoms, ulcers, or both persist beyond 8
to 12 weeks despite conventional treatment as
previously described or when several courses of H.
pylori eradication therapy fail
• Patient should undergo an upper endoscopy to
assess the situation
• Treatment depends on cause and may include
additional H. pylori eradication attempts, higher PPI
dosages, or surgery
 Dietary modifications may be necessary so that
foods and beverages irritating to patient can be
avoided or eliminated
 Protein considered best neutralizing food
◦ Stimulates gastric secretions
 Carbohydrates and fats are least stimulating to
HCl acid
secretion
◦ Do not neutralize well
 < 20% of patients with ulcers need
surgical intervention
 Indications for surgical interventions
Intractability
History of hemorrhage, ↑ risk of bleeding
Prepyloric or pyloric ulcers
Multiple ulcer sites
Drug-induced ulcers
Possible existence of a malignant ulcer
Obstruction
Surgical procedures
 Gastroduodenostomy
 Gastrojejunostomy
 Vagotomy
 Pyloroplasty
A. Billroth I Procedure B. Billroth II Procedure
Peptic ulcer diseases-2.pptx444444444444

More Related Content

Similar to Peptic ulcer diseases-2.pptx444444444444

Case presentation pud
Case presentation pudCase presentation pud
Case presentation pud
homebwoi
 

Similar to Peptic ulcer diseases-2.pptx444444444444 (20)

Peptic ulcer.pdf
Peptic ulcer.pdfPeptic ulcer.pdf
Peptic ulcer.pdf
 
Peptic ulcer disease
Peptic ulcer diseasePeptic ulcer disease
Peptic ulcer disease
 
Peptic ulcer disease
Peptic ulcer diseasePeptic ulcer disease
Peptic ulcer disease
 
peptic ulcer
peptic ulcerpeptic ulcer
peptic ulcer
 
peptic ulcer.pptx
peptic ulcer.pptxpeptic ulcer.pptx
peptic ulcer.pptx
 
Case presentation pud
Case presentation pudCase presentation pud
Case presentation pud
 
Gastroesophageal reflux disease
Gastroesophageal reflux diseaseGastroesophageal reflux disease
Gastroesophageal reflux disease
 
.pptx
.pptx.pptx
.pptx
 
Peptic ulcer of stomach and duodenum
Peptic ulcer of stomach and duodenumPeptic ulcer of stomach and duodenum
Peptic ulcer of stomach and duodenum
 
Gastritis
GastritisGastritis
Gastritis
 
Peptic ulcers.pptx
Peptic ulcers.pptxPeptic ulcers.pptx
Peptic ulcers.pptx
 
Peptic ulcers.pptx
Peptic ulcers.pptxPeptic ulcers.pptx
Peptic ulcers.pptx
 
PEPTIC ULCER DISEASE IN SURGICAL PRACTICE.pptx
PEPTIC ULCER DISEASE IN SURGICAL PRACTICE.pptxPEPTIC ULCER DISEASE IN SURGICAL PRACTICE.pptx
PEPTIC ULCER DISEASE IN SURGICAL PRACTICE.pptx
 
Ulcer Disease.pptx.pdf
Ulcer Disease.pptx.pdfUlcer Disease.pptx.pdf
Ulcer Disease.pptx.pdf
 
Acid Peptic Disease-1.pptx
Acid Peptic Disease-1.pptxAcid Peptic Disease-1.pptx
Acid Peptic Disease-1.pptx
 
PEPTIC ULCER.pptx
PEPTIC ULCER.pptxPEPTIC ULCER.pptx
PEPTIC ULCER.pptx
 
Peptic ulcer disease
Peptic ulcer diseasePeptic ulcer disease
Peptic ulcer disease
 
GI System Lecture 3
GI System Lecture 3GI System Lecture 3
GI System Lecture 3
 
Pud
PudPud
Pud
 
PUD.pptx
PUD.pptxPUD.pptx
PUD.pptx
 

More from samuellamaryk

CHEMICAL PATHOLOGY.pptx55555555555555555
CHEMICAL PATHOLOGY.pptx55555555555555555CHEMICAL PATHOLOGY.pptx55555555555555555
CHEMICAL PATHOLOGY.pptx55555555555555555
samuellamaryk
 
CHEMICAL PATHOLOGY.pptx55555555555555555
CHEMICAL PATHOLOGY.pptx55555555555555555CHEMICAL PATHOLOGY.pptx55555555555555555
CHEMICAL PATHOLOGY.pptx55555555555555555
samuellamaryk
 
PRESENTATION 5 CONVULSION.pptx1111111111
PRESENTATION 5 CONVULSION.pptx1111111111PRESENTATION 5 CONVULSION.pptx1111111111
PRESENTATION 5 CONVULSION.pptx1111111111
samuellamaryk
 
TYPHOID FEVER edited.pptx00000000000000
TYPHOID FEVER  edited.pptx00000000000000TYPHOID FEVER  edited.pptx00000000000000
TYPHOID FEVER edited.pptx00000000000000
samuellamaryk
 
Physiological changes in pregnancy (2).ppt
Physiological changes in pregnancy (2).pptPhysiological changes in pregnancy (2).ppt
Physiological changes in pregnancy (2).ppt
samuellamaryk
 
MEASLES.pptx4445544444444444444444444444
MEASLES.pptx4445544444444444444444444444MEASLES.pptx4445544444444444444444444444
MEASLES.pptx4445544444444444444444444444
samuellamaryk
 

More from samuellamaryk (6)

CHEMICAL PATHOLOGY.pptx55555555555555555
CHEMICAL PATHOLOGY.pptx55555555555555555CHEMICAL PATHOLOGY.pptx55555555555555555
CHEMICAL PATHOLOGY.pptx55555555555555555
 
CHEMICAL PATHOLOGY.pptx55555555555555555
CHEMICAL PATHOLOGY.pptx55555555555555555CHEMICAL PATHOLOGY.pptx55555555555555555
CHEMICAL PATHOLOGY.pptx55555555555555555
 
PRESENTATION 5 CONVULSION.pptx1111111111
PRESENTATION 5 CONVULSION.pptx1111111111PRESENTATION 5 CONVULSION.pptx1111111111
PRESENTATION 5 CONVULSION.pptx1111111111
 
TYPHOID FEVER edited.pptx00000000000000
TYPHOID FEVER  edited.pptx00000000000000TYPHOID FEVER  edited.pptx00000000000000
TYPHOID FEVER edited.pptx00000000000000
 
Physiological changes in pregnancy (2).ppt
Physiological changes in pregnancy (2).pptPhysiological changes in pregnancy (2).ppt
Physiological changes in pregnancy (2).ppt
 
MEASLES.pptx4445544444444444444444444444
MEASLES.pptx4445544444444444444444444444MEASLES.pptx4445544444444444444444444444
MEASLES.pptx4445544444444444444444444444
 

Recently uploaded

Failure to thrive in neonates and infants + pediatric case.pptx
Failure to thrive in neonates and infants  + pediatric case.pptxFailure to thrive in neonates and infants  + pediatric case.pptx
Failure to thrive in neonates and infants + pediatric case.pptx
claviclebrown44
 
Forensic medicine MCQ for early learners
Forensic medicine MCQ for early learnersForensic medicine MCQ for early learners
Forensic medicine MCQ for early learners
AlaguPandi5
 
Obat Aborsi Ampuh Usia 1,2,3,4,5,6,7 Bulan 081901222272 Obat Penggugur Kandu...
Obat Aborsi Ampuh Usia 1,2,3,4,5,6,7 Bulan  081901222272 Obat Penggugur Kandu...Obat Aborsi Ampuh Usia 1,2,3,4,5,6,7 Bulan  081901222272 Obat Penggugur Kandu...
Obat Aborsi Ampuh Usia 1,2,3,4,5,6,7 Bulan 081901222272 Obat Penggugur Kandu...
Halo Docter
 
Unveiling Pharyngitis: Causes, Symptoms, Diagnosis, and Treatment Strategies.pdf
Unveiling Pharyngitis: Causes, Symptoms, Diagnosis, and Treatment Strategies.pdfUnveiling Pharyngitis: Causes, Symptoms, Diagnosis, and Treatment Strategies.pdf
Unveiling Pharyngitis: Causes, Symptoms, Diagnosis, and Treatment Strategies.pdf
NoorulainMehmood1
 
Physiologic Anatomy of Heart_AntiCopy.pdf
Physiologic Anatomy of Heart_AntiCopy.pdfPhysiologic Anatomy of Heart_AntiCopy.pdf
Physiologic Anatomy of Heart_AntiCopy.pdf
MedicoseAcademics
 

Recently uploaded (20)

Face and Muscles of facial expression.pptx
Face and Muscles of facial expression.pptxFace and Muscles of facial expression.pptx
Face and Muscles of facial expression.pptx
 
Stereochemistry & Asymmetric Synthesis.pptx
Stereochemistry & Asymmetric Synthesis.pptxStereochemistry & Asymmetric Synthesis.pptx
Stereochemistry & Asymmetric Synthesis.pptx
 
BURNS (CLASSIFICATION & MANAGEMENTS).pdf
BURNS (CLASSIFICATION & MANAGEMENTS).pdfBURNS (CLASSIFICATION & MANAGEMENTS).pdf
BURNS (CLASSIFICATION & MANAGEMENTS).pdf
 
Storage of Blood Components- equipments, effects of improper storage, transpo...
Storage of Blood Components- equipments, effects of improper storage, transpo...Storage of Blood Components- equipments, effects of improper storage, transpo...
Storage of Blood Components- equipments, effects of improper storage, transpo...
 
Failure to thrive in neonates and infants + pediatric case.pptx
Failure to thrive in neonates and infants  + pediatric case.pptxFailure to thrive in neonates and infants  + pediatric case.pptx
Failure to thrive in neonates and infants + pediatric case.pptx
 
parliaments-for-health-security_RecordOfAchievement.pdf
parliaments-for-health-security_RecordOfAchievement.pdfparliaments-for-health-security_RecordOfAchievement.pdf
parliaments-for-health-security_RecordOfAchievement.pdf
 
Report Back from SGO: What’s the Latest in Ovarian Cancer?
Report Back from SGO: What’s the Latest in Ovarian Cancer?Report Back from SGO: What’s the Latest in Ovarian Cancer?
Report Back from SGO: What’s the Latest in Ovarian Cancer?
 
JOURNAL CLUB PRESENTATION TEMPLATE DOCUMENT
JOURNAL CLUB PRESENTATION TEMPLATE DOCUMENTJOURNAL CLUB PRESENTATION TEMPLATE DOCUMENT
JOURNAL CLUB PRESENTATION TEMPLATE DOCUMENT
 
Forensic medicine MCQ for early learners
Forensic medicine MCQ for early learnersForensic medicine MCQ for early learners
Forensic medicine MCQ for early learners
 
TEST BANK For Porth's Essentials of Pathophysiology, 5th Edition by Tommie L ...
TEST BANK For Porth's Essentials of Pathophysiology, 5th Edition by Tommie L ...TEST BANK For Porth's Essentials of Pathophysiology, 5th Edition by Tommie L ...
TEST BANK For Porth's Essentials of Pathophysiology, 5th Edition by Tommie L ...
 
Obat Aborsi Ampuh Usia 1,2,3,4,5,6,7 Bulan 081901222272 Obat Penggugur Kandu...
Obat Aborsi Ampuh Usia 1,2,3,4,5,6,7 Bulan  081901222272 Obat Penggugur Kandu...Obat Aborsi Ampuh Usia 1,2,3,4,5,6,7 Bulan  081901222272 Obat Penggugur Kandu...
Obat Aborsi Ampuh Usia 1,2,3,4,5,6,7 Bulan 081901222272 Obat Penggugur Kandu...
 
Unveiling Pharyngitis: Causes, Symptoms, Diagnosis, and Treatment Strategies.pdf
Unveiling Pharyngitis: Causes, Symptoms, Diagnosis, and Treatment Strategies.pdfUnveiling Pharyngitis: Causes, Symptoms, Diagnosis, and Treatment Strategies.pdf
Unveiling Pharyngitis: Causes, Symptoms, Diagnosis, and Treatment Strategies.pdf
 
Sell 5cladba adbb JWH-018 5FADB in stock
Sell 5cladba adbb JWH-018 5FADB in stockSell 5cladba adbb JWH-018 5FADB in stock
Sell 5cladba adbb JWH-018 5FADB in stock
 
seventh section physiology laboratory.pptx
seventh section physiology laboratory.pptxseventh section physiology laboratory.pptx
seventh section physiology laboratory.pptx
 
CONGENITAL HYPERTROPHIC PYLORIC STENOSIS by Dr M.KARTHIK EMMANUEL
CONGENITAL HYPERTROPHIC PYLORIC STENOSIS  by Dr M.KARTHIK EMMANUELCONGENITAL HYPERTROPHIC PYLORIC STENOSIS  by Dr M.KARTHIK EMMANUEL
CONGENITAL HYPERTROPHIC PYLORIC STENOSIS by Dr M.KARTHIK EMMANUEL
 
Drug development life cycle indepth overview.pptx
Drug development life cycle indepth overview.pptxDrug development life cycle indepth overview.pptx
Drug development life cycle indepth overview.pptx
 
How to buy 5cladba precursor raw 5cl-adb-a raw material
How to buy 5cladba precursor raw 5cl-adb-a raw materialHow to buy 5cladba precursor raw 5cl-adb-a raw material
How to buy 5cladba precursor raw 5cl-adb-a raw material
 
Overview on the Automatic pill identifier
Overview on the Automatic pill identifierOverview on the Automatic pill identifier
Overview on the Automatic pill identifier
 
Benefits of Chanting Hanuman Chalisa .pdf
Benefits of Chanting Hanuman Chalisa .pdfBenefits of Chanting Hanuman Chalisa .pdf
Benefits of Chanting Hanuman Chalisa .pdf
 
Physiologic Anatomy of Heart_AntiCopy.pdf
Physiologic Anatomy of Heart_AntiCopy.pdfPhysiologic Anatomy of Heart_AntiCopy.pdf
Physiologic Anatomy of Heart_AntiCopy.pdf
 

Peptic ulcer diseases-2.pptx444444444444

  • 2.  Mohamed lahai marrah (Leader)…..22065  Mohamed Adams jalloh……………..22027  Bandatin wilem conteh………………22014  Marian muyo kanu……………………22051  Kelfala hassan dawoh………………..22019  Foray kondeh ………………………….22056  Mohamed Alieu jalloh………………..22026
  • 3. Definition of peptic ulcer. Location and symptoms. Types. Etiology. Pathophysiology and pathogenesis Signs & symptoms Complications ,diagnostic studies and treatment. Precautions.
  • 4. • Peptic ulcer disease (PUD) refers to ulceration of the mucosa anywhere in the GI tract exposed to acid and pepsin. • Ulcers : breaks in the mucosal surface >5 mm, with depth to the sub-mucosa. • They can range in size from a few millimeters to a few centimeters • The 2 most common forms/locations of PUD are – Duodenal ulcer – Gastric ulcer  Site • Lower esophagus • Stomach • Duodenum
  • 5.  Under normal conditions, a physiologic balance exists between gastric acid secretion and gastroduodenal mucosal defense. Mucosal injury and, thus, peptic ulcer occur when the balance between the aggressive factors and the defensive mechanisms is disrupted. Aggressive factors, such as NSAIDs, H pylori infection, alcohol, bile salts, acid, and pepsin, can alter the mucosal defense by allowing back diffusion of hydrogen ions and subsequent epithelial cell injury.
  • 6.  Defensive ◦ Bicarbonate ◦ Mucus layer ◦ Prostaglandins ◦ Mucosal blood flow ◦ Epithelial renewal  Aggressive ◦ Helicobacter pylori ◦ NSAIDs ◦ Pepsins ◦ Bile acids ◦ Smoking and alcohol
  • 7. Ulcer may be found : In oesophagus,  stomach, duedonum jejunum at multiple levels (Zollinger Ellison syndrome).
  • 8. Acute • Superficial erosion • Minimal erosion Chronic • Muscular wall erosion with formation of fibrous tissue • Present continuously for many months or intermittently
  • 9. • Common causes of PUD – Helicobacter pylori (H.pylori) infection – Nonsteroidal Anti-inflammatory Drugs (NSAIDs) – Critical illness (stress-related mucosal damage) • Uncommon causes of PUD – Idiopathic (non-H.pylori, non- NSAID) – Hypersecretion of gastric acid (e.g. Zollinger Ellison syndrome) – Viral infections – Radiation therapy – Chemotherapy
  • 10.  Helicobacter pylori (HP) is a spiral shaped, gram negative, flagellated bacteria first associated with PUD in the early 1980’s  Found in most people with duodenal and gastric ulcers ◦ About 95% of those with duodenal ulcers ◦ About 80% of those with gastric ulcers  HP is primarily spread through the fecal to oral route  Oral – oral routes  Through contaminated food and water  People are most often infected during childhood
  • 11.  Mechanisms by which HP causes mucosal injury are not entirely clear but occurs through a combination of the following mechanisms: ◦ HP catalyzes urea  ammonia is produced  ammonia erodes the mucous barrier and causes epithelial damage ◦ HP produces cytotoxins ◦ HP produces mucolytic enzymes PATHOGENESIS
  • 12.  In long-term NSAID users, there is a 10% - 20% prevalence of gastric ulcers and a 2% - 5% prevalence of duodenal ulcers  Mechanisms for NSAID-induced ulceration ◦ NSAIDs are weak acids and are non-ionized at gastric pH  Diffuse freely across the mucous barrier into gastric epithelial cells  H+ ions are liberated and cause cellular damage • Aspirin is the most ulcerno-genic of all NSAIDs. – Even with low dose aspirin (81-162mg/day), ulcers occur in 0.6% - 1.2% of patients per year
  • 13. • NSAIDs inhibit cyclooxygenase activity and therefore decrease prostaglandin production which results in a:  Reduction in gastric and mucosal blood flow  Decrease in mucous and bicarbonate secretion  Decrease in cellular repair and replication
  • 14. • ZES is characterized by gastric acid hypersecretion and recurrent peptic ulcers that result from a gastrin-producing tumor –More than 50% of gastrinomas are malignant • ZES is suspected for patients with multiple ulcers and recurrent or refractory PUD often accompanied by esophagitis or ulcer complications • Only accounts for 0.1% to 1% of those with duodenal ulcer
  • 15. • Cigarette smoking – Impairs ulcer healing and increases the risk of recurrence • Psychological stress – Stress may induce behavioral risks such as smoking and the use of NSAIDs or may alter the inflammatory response or resistance to HP infection • Dietary factors – Certain foods (e.g. coffee, tea, carbonated beverages, beer, milk, spices) may cause dyspepsia but do not increase the risk of developing PUD
  • 16. Signs &Symptoms Abdominal discomfort usually occurs in epigastric area (upper middle part of the abdomen) radiating to the back described as: dull gnawing ache comes and goes for several days pain may increase when the stomach is empty at night or half to three hours after meal. Pain is relieved by eating & antacid medication. Weight change Fatigue Bloating Chest pain Burping Nausea and Anorexia (common with gastric ulcer) Vomiting (relieves episodes of severe pain due to evacuation of gastric acid content). Heart burn
  • 17. Emergency symptoms: If you have any of these symptoms call your doctor right away: Sharp sudden persistent abdominal pain. Bloody or black stools. Bloody vomit or vomit that looks like coffee grounds. Dysphagia They could be signs of a serious problem such as: Perforation when the ulcer burrows through the stomach or duodenal wall.
  • 18.
  • 19.  Less common than duodenal ulcers ◦ Especially in chronic NSAID use  Most commonly located in the lesser curvature of the antrum of the stomach  More common in people greater than 60 years old Characterized by • A normal to low secretion of gastric acid • Back diffusion of acid is greater (chronic ) • Critical pathologic process is amount of acid able to penetrate mucosal barrier • H pylori is present in 50% to 70% • Drugs --- Aspirin, corticosteroids, N SAIDs, reserpine, Chronic alcohol abuse, chronic gastritis
  • 20.  Most common form of PUD ◦ It is 3 times more common than gastric ulcers  Usually located in the duodenal bulb of the small intestine  Most commonly occurs in people between the ages of 30 and 50  Associated with ↑HCl acid secretion  H.pylori associated in 9 0- 9 5 % of cases  Diseases with ↑risk of duodenal ulcers COPD, cirrhosis of liver, chronic pancreatitis, hyperparathyroidism, chronic renal failure
  • 21.  3 major complications Hemorrhage - 15% of patients with active PUD Perforation - 7% of patients with active PUD Gastric outlet obstruction  Initially treated conservatively  May require surgery at any time during course of therapy
  • 22.
  • 23.
  • 24.  The second most common ulcer – related complications is perforation( occur in 6-7% of PUD patients)  Dus tend to penetrate posteriorly in to the pancrease, leading to pancreatitis, whereas Gus tend to penetrate in to the left hepatic lobe.
  • 25.  Gastric outlet obstruction is the least common ulcer-related complications,occuring in 1-2% of patients
  • 26.  Endoscopy procedure ◦ Determines degree of ulcer healing after treatment ◦ Tissue specimens can be obtained to identify H. pylori and to rule out gastric cancer  Tests for H.pylori ◦ Noninvasive tests  Serum or whole blood antibody tests  Immunoglobin G (I g G)  Urea breath test  C 14 breath test  Fecal antigen test ◦ Invasive tests  Biopsy of stomach  Rapid urease test
  • 27.  The urea breath and fecal antigen tests may be falsely negative in patients who have recently taken ◦ Antibiotics (up to 4 weeks) ◦ Bismuth compounds (up to 4 weeks) ◦ Antisecretory agents (up to 2 weeks)
  • 28.  Barium contrast studies ◦ Widely used  X- ray studies ◦ Ineffective in differentiating a peptic ulcer from a malignant tumor
  • 29.
  • 30. Medical regimen consists of ◦ Adequate rest ◦ Dietary modification ◦ Drug therapy ◦ Elimination of risk factors ◦ Long-term follow-up care
  • 31. • Antacids • H2 receptor blockers • PPIs • Antibiotics • Anticholinergics • Cytoprotective therapy
  • 32. Histamine receptor blocks (H2 R blockers)- famotidine,cimetidine  Used to manage peptic ulcer disease  Block action of histamine on H2 receptors ↓ HCl acid secretion ↓ conversion of pepsinogen to pepsin ↑ ulcer healing Proton pump inhibitors – pantoprazole, rabeprazole ◦ Block ATPase enzyme that is important for secretion of HCl acid Antibiotic therapy ◦ Eradicate H. pylori infection ◦ No single agents have been effective in eliminating H. pylori
  • 33.  Antacids – calcium carbonate, MgOH ◦ Used as adjunct therapy for peptic ulcer disease ◦ ↑ gastric pH by neutralizing acid  Anticholinergic drugs- Dicyclomine ◦ Occasionally ordered for treatment ◦ ↓ cholinergic stimulation of HCl acid • Bismuth preparations • Agents – Bismuth subsalicylate – Bismuth exhibits antimicrobial activity against bacterial and viral gastrointestinal pathogens
  • 34.  Standard triple therapy regimen contains ◦ Amoxicillin 1000mg twice day + Clarithromycin 500mg twice a day + a PPI dosed once to twice a day ◦ Given for 10 to 14 days  14 day regimens are generally preferred as 14 day regimens significantly increases the eradication rate  Bismuth-based quadruple-therapy contains ◦ Tetracycline 500mg 4 times day +Metronidazole 250- 500mg 2/3 times a day + Bismuth subsalicylate 525mg 4 times a day + a PPI once or twice a day OR H2-receptor antagonist twice a day
  • 35. • When symptoms, ulcers, or both persist beyond 8 to 12 weeks despite conventional treatment as previously described or when several courses of H. pylori eradication therapy fail • Patient should undergo an upper endoscopy to assess the situation • Treatment depends on cause and may include additional H. pylori eradication attempts, higher PPI dosages, or surgery
  • 36.  Dietary modifications may be necessary so that foods and beverages irritating to patient can be avoided or eliminated  Protein considered best neutralizing food ◦ Stimulates gastric secretions  Carbohydrates and fats are least stimulating to HCl acid secretion ◦ Do not neutralize well
  • 37.  < 20% of patients with ulcers need surgical intervention  Indications for surgical interventions Intractability History of hemorrhage, ↑ risk of bleeding Prepyloric or pyloric ulcers Multiple ulcer sites Drug-induced ulcers Possible existence of a malignant ulcer Obstruction
  • 38. Surgical procedures  Gastroduodenostomy  Gastrojejunostomy  Vagotomy  Pyloroplasty
  • 39. A. Billroth I Procedure B. Billroth II Procedure